5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.56▲ | 0.58▼ | 0.61▼ | 0.44▲ | 0.42▲ |
MA10 | 0.56▲ | 0.61▼ | 0.54▲ | 0.38▲ | 0.80▼ |
MA20 | 0.56▲ | 0.53▲ | 0.48▲ | 0.39▲ | 3.43▼ |
MA50 | 0.62▼ | 0.46▲ | 0.42▲ | 1.34▼ | 2.03▼ |
MA100 | 0.56▲ | 0.41▲ | 0.39▲ | 3.85▼ | 15.11▼ |
MA200 | 0.49▲ | 0.39▲ | 0.48▲ | 2.18▼ | 686.02▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | -0.006▼ | 0.012▲ | 0.131▲ | -0.472▼ |
RSI | 42.856▼ | 54.271▲ | 59.463▲ | 42.346▼ | 40.576▼ |
STOCH | 58.087 | 32.083 | 63.968 | 66.169 | 3.499▼ |
WILL %R | -26.096 | -58.526 | -56.284 | -39.270 | -97.914▼ |
CCI | 71.045 | -45.465 | 36.124 | 290.458▲ | -54.834 |
Thursday, May 01, 2025 12:23 PM
TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial of TTX-MC138, an RNA-based therapeutic targeting microRNA-10b ...
|
Thursday, May 01, 2025 11:29 AM
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. LOS ANGELES, CA - May 1, 2025 (NEWMEDIAWIRE) - ...
|
Thursday, May 01, 2025 08:32 AM
TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial of TTX-MC138, an RNA-based therapeutic targeting microRNA-10b in metastatic cancer. Thirteen patients have ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.4782 | 0.7867 | 0.4636 | 0.564 | 130,337,970 |
30/04/25 | 0.425 | 0.425 | 0.3866 | 0.4066 | 1,811,559 |
29/04/25 | 0.4141 | 0.4399 | 0.4141 | 0.4232 | 1,070,572 |
28/04/25 | 0.38 | 0.44 | 0.38 | 0.4218 | 3,201,118 |
25/04/25 | 0.409 | 0.5004 | 0.38 | 0.38 | 7,309,532 |
24/04/25 | 0.3165 | 0.4681 | 0.3165 | 0.40 | 10,254,358 |
23/04/25 | 0.33 | 0.345 | 0.3135 | 0.314 | 2,018,497 |
22/04/25 | 0.3178 | 0.326 | 0.285 | 0.3109 | 2,338,831 |
21/04/25 | 0.2784 | 0.385 | 0.2784 | 0.30 | 13,314,395 |
17/04/25 | 0.3507 | 0.3577 | 0.2196 | 0.2725 | 5,689,080 |
|
|
||||
|
|
||||
|
|